LONG-TERM SURVIVAL IN CHRONIC MYELOGENOUS LEUKEMIA (CML) - ARE THERE ANY PROGNOSTIC FACTORS

被引：0
|
作者：
PRISCHL, F
SCHWARZMEIER, J
HAAS, O
GRANINGER, W
机构：
[1] VIENNA UNIV,MED CLIN 1,A-1010 VIENNA,AUSTRIA
[2] VIENNA UNIV,CHEMOTHERAPY CLIN,A-1010 VIENNA,AUSTRIA
[3] ST ANNA CHILDRENS HOSP,VIENNA,AUSTRIA
来源：
BLUT | 1984年 / 49卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：224 / 224
页数：1
相关论文
共 50 条
  • [41] Survival-weighted health profile for long-term survivors of acute myelogenous leukemia
    Chiun Hsu
    Jung-Der Wang
    Jing-Shiang Hwang
    Hwei-Fang Tien
    Shueh-Mei Chang
    Ann-Lii Cheng
    Yao-Chang Chen
    Jih-Luh Tang
    Quality of Life Research, 2003, 12 : 503 - 517
  • [42] Prognostic factors associated with long-term survival in ovarian cancer
    Cress, R.
    Morris, C.
    Chen, Y.
    Leiserowitz, G.
    GYNECOLOGIC ONCOLOGY, 2014, 135 (02) : 391 - 391
  • [43] Survival-weighted health profile for long-term survivors of acute myelogenous leukemia
    Hsu, C
    Wang, JD
    Hwang, JS
    Tien, HF
    Chang, SM
    Cheng, AL
    Chen, YC
    Tang, JL
    QUALITY OF LIFE RESEARCH, 2003, 12 (05) : 503 - 517
  • [44] Long-term survival in advanced chronic myelogenous leukemia following bone marrow transplantation from haploidentical related donors
    Bishop, MR
    HensleeDowney, PJ
    Anderson, JR
    Romond, EH
    Marciniak, E
    Yankey, R
    Reeves, M
    Thompson, JS
    BONE MARROW TRANSPLANTATION, 1996, 18 (04) : 747 - 753
  • [45] ANALYSIS OF PROGNOSTIC FACTORS IN 303 PATIENTS (PTS) WITH PHILADELPHIA POSITIVE (PH+VE) CHRONIC MYELOGENOUS LEUKEMIA (CML)
    KANTARJIAN, H
    SMITH, T
    MCCREDIE, K
    KEATING, M
    HESTER, J
    WALTERS, R
    FREIREICH, E
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1984, 25 (MAR): : 186 - 186
  • [46] SURVIVAL IN CHRONIC MYELOGENOUS LEUKEMIA
    GOLDMAN, JM
    BLOOD, 1994, 83 (05) : 1443 - 1443
  • [47] Survival with chronic myelogenous leukemia
    Ozet, A
    Ozet, G
    Caliskaner, Z
    Komurcu, S
    Arpaci, F
    Berk, O
    ONCOLOGY, 1997, 54 (06) : 516 - 516
  • [48] Integrative prognostic models predict long-term survival after immunochemotherapy in chronic lymphocytic leukemia patients
    Bloehdorn, Johannes
    Krzykalla, Julia
    Holzmann, Karlheinz
    Gerhardinger, Andreas
    Jebaraj, Billy Michael Chelliah
    Bahlo, Jasmin
    Humphrey, Kathryn
    Tausch, Eugen
    Robrecht, Sandra
    Mertens, Daniel
    Schneider, Christof
    Fischer, Kirsten
    Hallek, Michael
    Doehner, Hartmut
    Benner, Axel
    Stilgenbauer, Stephan
    HAEMATOLOGICA, 2022, 107 (03) : 615 - 624
  • [49] PROJECTING THE LONG-TERM SURVIVAL OF NEWLY DIAGNOSED PATIENTS WITH CHRONIC MYELOID LEUKEMIA (CML) IN CHRONIC PHASE (CP) RECEIVING NILOTINIB OR IMATINIB
    Botteman, F.
    Stephens, J.
    Coombs, J.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 348 - 348
  • [50] The prognostic significance of early molecular and cytogenetic response for long-term progression-free and overall survival in imatinib-treated chronic myeloid leukemia (CML).
    Hehlmann, Rudiger
    Hanfstein, Benjamin
    Mueller, Martin C.
    Erben, Philipp
    Lauseker, Michael
    Fabarius, Alice
    Schnittger, Susanne
    Haferlach, Claudia
    Goehring, Gudrun
    Krause, Stefan W.
    Dengler, Jolanta
    Falge, Christiane
    Neubauer, Andreas
    Stegelmann, Frank
    Pfreundschuh, Michael
    Spiekermann, Karsten
    Baerlocher, Gabriela M.
    Hasford, Joerg
    Saussele, Susanne
    Hochhaus, Andreas
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
12345